AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35697942 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training
Number of subjects: 105
Study 35697942 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 105
Study 33562001 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy with an individually selected diet plan
Number of subjects: 60
Study 33562001 — intervention group
Group type: COMPARATOR
Intervention: Traditional slimming therapies using an individual diet plan and dietitian’s care
Number of subjects: 60
Study 34357781 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg by mouth once daily and entinostat 5 mg by mouth once weekly (EE)
Number of subjects: 608
Study 34357781 — intervention group
Group type: COMPARATOR
Intervention: Exemestane 25 mg by mouth once daily and placebo 5 mg by mouth once weekly (EP)
Number of subjects: 608
Study 34990582 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography-derived physiology guided PCI
Number of subjects: 2540
Study 34990582 — intervention group
Group type: COMPARATOR
Intervention: Usual care PCI
Number of subjects: 2540
Study 34184336 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron preoperatively
Number of subjects: 0
Study 34184336 — intervention group
Group type: COMPARATOR
Intervention: No intravenous iron (control group)
Number of subjects: 0
Study 32197956 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 15 mg
Number of subjects: 28
Study 32197956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 36339068 — intervention group
Group type: EXPERIMENTAL
Intervention: esmolol
Number of subjects: 30
Study 36339068 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine
Number of subjects: 30
Study 36339068 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 32358640 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (AminoAlta™, a multi-strain probiotic with 5 billion CFU L. paracasei LP-DG® and 5 billion CFU L. paracasei LPC-S01)
Number of subjects: 15
Study 32358640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35938852 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month reduced-calorie weight-loss diet and exercise programme
Number of subjects: 192
Study 35938852 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 192
Study 35938852 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss interventions (≥10% weight loss)
Number of subjects: 192
Study 35938852 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss interventions (0-10% weight loss)
Number of subjects: 192
Study 33092758 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial strain-guided LV lead placement with multimodality imaging
Number of subjects: 102
Study 33092758 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard CRT lead placement)
Number of subjects: 102
Study 33092758 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial strain-guided LV lead placement
Number of subjects: 102
Study 33092758 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 34054079 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser PBM (λ = 808 nm, optical output = 100 mW, total energy = 42 J)
Number of subjects: 22
Study 34054079 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser PBM
Number of subjects: 22
Study 34054079 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 22
Study 33120085 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation analysis using Mendelian randomization approach
Number of subjects: 592
Study 33120085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression data analysis
Number of subjects: 592
Study 32703245 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally based palliative care tele-consult program (n=176)
Number of subjects: 352
Study 32703245 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care (n=176)
Number of subjects: 352
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in PDAC patients
Number of subjects: 302
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in highly differentiated PDAC
Number of subjects: 302
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in intermediate differentiated PDAC
Number of subjects: 302
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in low differentiated PDAC
Number of subjects: 302
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of CLDN18.2 positivity with clinicopathological characteristics
Number of subjects: 302
Study 35656795 — intervention group
Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity and survival prediction
Number of subjects: 302
Study 34051666 — intervention group
Group type: EXPERIMENTAL
Intervention: External Focus of Modeling (EFM)
Number of subjects: 24
Study 34051666 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Focus of Modeling (IFM)
Number of subjects: 24
Study 34051666 — intervention group
Group type: COMPARATOR
Intervention: Both groups (EFM and IFM)
Number of subjects: 24
Study 36071317 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette depicting low support needs
Number of subjects: 499
Study 36071317 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette depicting high support needs
Number of subjects: 499
Study 36071317 — intervention group
Group type: COMPARATOR
Intervention: Participants' nationality (South Korean vs. American)
Number of subjects: 499
Study 33512442 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 145
Study 33512442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 35666289 — intervention group
Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg (continuous usage)
Number of subjects: 100
Study 35666289 — intervention group
Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg (on-demand usage)
Number of subjects: 100
Study 34242498 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen (NBO) at 8 L/min
Number of subjects: 50
Study 34242498 — intervention group
Group type: COMPARATOR
Intervention: Control group (room air)
Number of subjects: 50
Study 32255318 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of nephrotoxic agents
Number of subjects: 80
Study 34523193 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery-based self-regulation intervention (physical activity)
Number of subjects: 500
Study 34523193 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk ladder condition (physical activity)
Number of subjects: 500
Study 34523193 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal planning
Number of subjects: 500
Study 34523193 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy, image clarity, and affective attitudes
Number of subjects: 500
Study 33040481 — intervention group
Group type: EXPERIMENTAL
Intervention: FHNSI-10
Number of subjects: 239
Study 33040481 — intervention group
Group type: EXPERIMENTAL
Intervention: FHNSI-7
Number of subjects: 239
Study 33040481 — intervention group
Group type: EXPERIMENTAL
Intervention: FHNSI-10, FHNSI-7, pain, fatigue, swallowing, and breathing symptom scores
Number of subjects: 239
Study 33040481 — intervention group
Group type: EXPERIMENTAL
Intervention: FHNSI-10, FHNSI-7, pain, fatigue, and breathing symptom scores
Number of subjects: 239
Study 33040481 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom indexes and individual symptom scores
Number of subjects: 239
Study 35668503 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with nicotine patch
Number of subjects: 96
Study 35668503 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture combined with sham nicotine patch
Number of subjects: 96
Study 35668503 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture combined with nicotine patch
Number of subjects: 96
Study 35668503 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture combined with sham nicotine patch
Number of subjects: 96
Study 32724929 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Turkish music (Saba or Rast Tune)
Number of subjects: 80
Study 32724929 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music (Vivaldi)
Number of subjects: 80
Study 32724929 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow rock music
Number of subjects: 80
Study 32724929 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 80
Study 35357671 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (Xywav®)
Number of subjects: 0
Study 35357671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33125623 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Function-Based Intervention for Elopement
Number of subjects: 24
Study 32721482 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration with resin composite core (EBC)
Number of subjects: 60
Study 32721482 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration with resin composite core and a fiber post (EBP)
Number of subjects: 60
Study 32721482 — intervention group
Group type: COMPARATOR
Intervention: No restoration (EB)
Number of subjects: 60
Study 32721482 — intervention group
Group type: COMPARATOR
Intervention: Intact teeth (Control)
Number of subjects: 60
Study 35538481 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal active learning (flipped classroom and modified Peyton's 4-steps method)
Number of subjects: 89
Study 35538481 — intervention group
Group type: COMPARATOR
Intervention: Simulation alone (control group)
Number of subjects: 89
Study 35538481 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal active learning
Number of subjects: 89
Study 35538481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 89
Study 32007834 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise intervention
Number of subjects: 217
Study 32007834 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 217
Study 32041190 — intervention group
Group type: EXPERIMENTAL
Intervention: CDSS (Clinical Decision Support System) prompting delivery of a brief alcohol intervention (educational alcohol resource)
Number of subjects: 5702
Study 32041190 — intervention group
Group type: COMPARATOR
Intervention: No CDSS (Control)
Number of subjects: 5702
Study 35789530 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification combined with TEAS four times weekly for 12 weeks
Number of subjects: 60
Study 35789530 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modification
Number of subjects: 60
Study 33832145 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) stimulation of the suprascapular nerve
Number of subjects: 90
Study 33832145 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 90
Study 33832145 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PRF stimulation and physical therapy
Number of subjects: 90
Study 33832145 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 36056378 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling intervention in ICU
Number of subjects: 28
Study 36056378 — intervention group
Group type: COMPARATOR
Intervention: Routine physiotherapy
Number of subjects: 28
Study 33789009 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.3 mg/kg every 3 weeks
Number of subjects: 106
Study 33789009 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.7 mg/kg every 3 weeks
Number of subjects: 106
Study 33789009 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept
Number of subjects: 106
Study 33789009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 36263522 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 60
Study 36263522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33326970 — intervention group
Group type: EXPERIMENTAL
Intervention: ART sealants
Number of subjects: 187
Study 33326970 — intervention group
Group type: COMPARATOR
Intervention: Nonsealed molars
Number of subjects: 187
Study 35936770 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful Aging Group (SAG)
Number of subjects: 56
Study 35936770 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity Group (PAG)
Number of subjects: 56
Study 35936770 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful Aging Group (SAG) females
Number of subjects: 56
Study 32331041 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin (PIM) 34 mg/day
Number of subjects: 207
Study 32331041 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 207
Study 36175968 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose titrated morphine hydrochloride administered intravenously for 24 hours
Number of subjects: 22
Study 36175968 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl) administered for 24 hours
Number of subjects: 22
Study 33975133 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model predicting disposition based on triage assessment and historical information.
Number of subjects: 585142
Study 33975133 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model performance analysis.
Number of subjects: 585142
Study 32734722 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional tunica vaginalis flap coverage
Number of subjects: 50
Study 32734722 — intervention group
Group type: COMPARATOR
Intervention: Dartos-only coverage (Control)
Number of subjects: 50
Study 35229658 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 0
Study 35229658 — intervention group
Group type: COMPARATOR
Intervention: Usual care (implied control)
Number of subjects: 0
Study 32900246 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) at 40% of maximal inspiratory pressure (IPmax) for 20 min/session, thrice/week, over 12 weeks
Number of subjects: 34
Study 32900246 — intervention group
Group type: COMPARATOR
Intervention: Placebo IMT at 5% of IPmax
Number of subjects: 34
Study 33371126 — intervention group
Group type: EXPERIMENTAL
Intervention: Pingmu Decoction combined with acupuncture
Number of subjects: 120
Study 33371126 — intervention group
Group type: COMPARATOR
Intervention: Basic western medicine treatment
Number of subjects: 120
Study 33371126 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse reactions
Number of subjects: 120
Study 36149241 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern external ring fixation (n = 127)
Number of subjects: 254
Study 36149241 — intervention group
Group type: COMPARATOR
Intervention: Internal fixation (n = 133)
Number of subjects: 254
Study 36149241 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern external ring fixation
Number of subjects: 254
Study 36149241 — intervention group
Group type: COMPARATOR
Intervention: Internal fixation
Number of subjects: 254
Study 34682375 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition A (Self and Elaboration)
Number of subjects: 84
Study 34682375 — intervention group
Group type: COMPARATOR
Intervention: Condition B (Self and No Elaboration)
Number of subjects: 84
Study 34682375 — intervention group
Group type: COMPARATOR
Intervention: Condition C (Other and Elaboration)
Number of subjects: 84
Study 34682375 — intervention group
Group type: COMPARATOR
Intervention: Condition D (Other and No Elaboration)
Number of subjects: 84
Study 32975076 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐382‐5p mimics
Number of subjects: 0
Study 32975076 — intervention group
Group type: EXPERIMENTAL
Intervention: pc‐PTEN
Number of subjects: 0
Study 32975076 — intervention group
Group type: EXPERIMENTAL
Intervention: mimics+pc‐PTEN
Number of subjects: 0
Study 32975076 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34366201 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Therapeutic Education System (TES) for 12 weeks
Number of subjects: 206
Study 34366201 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 206
Study 33339609 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol 2 μg/d started 48 hours before surgery and continued throughout the hospital stay
Number of subjects: 86
Study 33339609 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alfacalcidol treatment)
Number of subjects: 86
Study 32580676 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious Illness Conversation Guide
Number of subjects: 25
Study 32580676 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation in EHR template
Number of subjects: 25
Study 32580676 — intervention group
Group type: COMPARATOR
Intervention: Documentation in progress notes
Number of subjects: 25
Study 32580676 — intervention group
Group type: COMPARATOR
Intervention: No documentation
Number of subjects: 25
Study 33010803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal-iliohypogastric block (US-ILIHB) with 0.2% ropivacaine after anesthesia induction
Number of subjects: 103
Study 33010803 — intervention group
Group type: COMPARATOR
Intervention: Perifocal wound infiltration (PWI) with 0.2% ropivacaine performed by a surgeon before wound closure
Number of subjects: 103
Study 33010803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal-iliohypogastric block (US-ILIHB)
Number of subjects: 103
Study 35249118 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS-2 supplementation with whey protein
Number of subjects: 100
Study 35249118 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (lactose with whey protein)
Number of subjects: 100
Study 32223112 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (10 mg twice daily for the first 7 days, followed by 5 mg twice daily)
Number of subjects: 1155
Study 32223112 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin (200 IU per kilogram once daily for the first month, followed by 150 IU per kilogram once daily)
Number of subjects: 1155
Study 36347151 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Mindfulness-Based Intervention (MBI)
Number of subjects: 65
Study 36347151 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 65
Study 33010590 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailand shoe
Number of subjects: 20
Study 33010590 — intervention group
Group type: EXPERIMENTAL
Intervention: OrthoWedge shoe
Number of subjects: 20
Study 33010590 — intervention group
Group type: EXPERIMENTAL
Intervention: Podalux shoe
Number of subjects: 20
Study 33010590 — intervention group
Group type: COMPARATOR
Intervention: Reference shoe
Number of subjects: 20
Study 35092723 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) pathway incorporating a digital tool
Number of subjects: 1200
Study 35092723 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study 33098633 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS), exposure rate 1.8%, typically >2 weeks before delivery.
Number of subjects: 13976
Study 33098633 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS)
Number of subjects: 13976
Study 33098633 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ACS exposure)
Number of subjects: 13976
Study 35034195 — intervention group
Group type: COMPARATOR
Intervention: COPD patients during sleep
Number of subjects: 21
Study 33727868 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam Daabo six-component intervention
Number of subjects: 1120
Study 33727868 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal and postnatal care (Control)
Number of subjects: 1120
Study 35852611 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power (45 W)
Number of subjects: 130
Study 35852611 — intervention group
Group type: COMPARATOR
Intervention: Moderate-power (35 W)
Number of subjects: 130
Study 34402789 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemi Enoxaparin (80 mg/0.8 mL)
Number of subjects: 47
Study 34402789 — intervention group
Group type: COMPARATOR
Intervention: Clexane (80 mg/0.8 mL)
Number of subjects: 47
Study 32815902 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV assisted partner services (aPS)
Number of subjects: 550
Study 36028897 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin
Number of subjects: 72
Study 36028897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33404865 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Milk Formula (PMF)
Number of subjects: 40
Study 33404865 — intervention group
Group type: COMPARATOR
Intervention: Skimmed milk drink formula (placebo)
Number of subjects: 40
Study 33927023 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 36
Study 33927023 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 36
Study 35680539 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) delivered by trained staff over 8–12 weeks using a structured workbook
Number of subjects: 188
Study 35680539 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) delivered by trained staff
Number of subjects: 188
Study 33378217 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual arousal up-regulation
Number of subjects: 255
Study 33378217 — intervention group
Group type: EXPERIMENTAL
Intervention: Disgust down-regulation
Number of subjects: 255
Study 33378217 — intervention group
Group type: COMPARATOR
Intervention: Passive control condition
Number of subjects: 255
Study 33784930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan (LTN)
Number of subjects: 14100
Study 33784930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14100
Study 35869734 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium butyricum capsules combined with rosuvastatin
Number of subjects: 96
Study 34559581 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 68
Study 34559581 — intervention group
Group type: COMPARATOR
Intervention: Endurance training
Number of subjects: 68